[go: up one dir, main page]

ES499262A0 - Procedimiento para la obtencion de un microorganismo que forma un polipetido con la secuencia de aminoacidos del inter- feron de leucocitos humanos. - Google Patents

Procedimiento para la obtencion de un microorganismo que forma un polipetido con la secuencia de aminoacidos del inter- feron de leucocitos humanos.

Info

Publication number
ES499262A0
ES499262A0 ES499262A ES499262A ES499262A0 ES 499262 A0 ES499262 A0 ES 499262A0 ES 499262 A ES499262 A ES 499262A ES 499262 A ES499262 A ES 499262A ES 499262 A0 ES499262 A0 ES 499262A0
Authority
ES
Spain
Prior art keywords
interferon
polypetyde
procedure
obtaining
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES499262A
Other languages
English (en)
Other versions
ES8205428A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES499262A0 publication Critical patent/ES499262A0/es
Publication of ES8205428A1 publication Critical patent/ES8205428A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES499262A 1980-02-16 1981-02-10 Procedimiento para la obtencion de un microorganismo que forma un polipetido con la secuencia de aminoacidos del inter- feron de leucocitos humanos. Expired ES8205428A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803005897 DE3005897A1 (de) 1980-02-16 1980-02-16 Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus

Publications (2)

Publication Number Publication Date
ES499262A0 true ES499262A0 (es) 1982-06-01
ES8205428A1 ES8205428A1 (es) 1982-06-01

Family

ID=6094832

Family Applications (3)

Application Number Title Priority Date Filing Date
ES499259A Granted ES499259A0 (es) 1980-02-16 1981-02-10 Procedimiento para la preparacion microbiologica de un polipeptido que contiene total o parcialmente la secuencia de a- minoacidos del interferon de leucocitos humanos.
ES499262A Expired ES8205428A1 (es) 1980-02-16 1981-02-10 Procedimiento para la obtencion de un microorganismo que forma un polipetido con la secuencia de aminoacidos del inter- feron de leucocitos humanos.
ES499261A Granted ES499261A0 (es) 1980-02-16 1981-02-10 Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de leuco- citos humanos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES499259A Granted ES499259A0 (es) 1980-02-16 1981-02-10 Procedimiento para la preparacion microbiologica de un polipeptido que contiene total o parcialmente la secuencia de a- minoacidos del interferon de leucocitos humanos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES499261A Granted ES499261A0 (es) 1980-02-16 1981-02-10 Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de leuco- citos humanos.

Country Status (13)

Country Link
EP (1) EP0034307B1 (es)
JP (1) JPS56158793A (es)
AT (1) ATE26463T1 (es)
AU (1) AU6728881A (es)
BE (1) BE887529A (es)
DE (2) DE3005897A1 (es)
ES (3) ES499259A0 (es)
FR (1) FR2478124A1 (es)
GB (1) GB2071108A (es)
IT (1) IT1141977B (es)
NL (1) NL8100718A (es)
SE (1) SE8101005L (es)
ZA (1) ZA81975B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU564690B2 (en) 1980-04-03 1987-08-20 Biogen Idec Ma Inc. Process for producing human fibroblast interferon-like polypeptides using recombinant dna
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
JPS58116498A (ja) * 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Ｉｌ‐２をコードする新規伝令ｒｎａの製造法
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
SU1364343A1 (ru) * 1984-07-13 1988-01-07 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Способ получени человеческого лейкоцитарного интерферона альфа-2
AU4070897A (en) * 1996-08-16 1998-03-06 Kurt B. Osther Method for treating diabetes
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
EP2013225B1 (en) 2006-04-12 2014-12-17 Crealta Pharmaceuticals LLC Purification of proteins with cationic surfactant
WO2009045553A1 (en) 2007-10-05 2009-04-09 Barofold, Inc. High pressure treatment of aggregated interferons
PL398781A1 (pl) 2009-06-25 2012-11-19 Savient Pharmaceuticals, Inc. Sposoby i zestawy do prognozowania ryzyka wystapienia reakcji na wlew oraz zaniku odpowiedzi której posrednicza przeciwciala poprzez monitorowanie kwasu moczowego w surowicy podczas terapii z zastosowaniem pegylowanej urykazy
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
EP3538135A4 (en) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
NO164037C (no) * 1980-01-08 1990-08-22 Biogen Inc Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type.
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein

Also Published As

Publication number Publication date
JPS56158793A (en) 1981-12-07
IT1141977B (it) 1986-10-08
ZA81975B (en) 1982-03-31
ES8301502A1 (es) 1982-12-01
EP0034307B1 (de) 1987-04-08
ES8205431A1 (es) 1982-06-01
ATE26463T1 (de) 1987-04-15
DE3005897A1 (de) 1981-09-03
ES499261A0 (es) 1982-06-01
ES8205428A1 (es) 1982-06-01
EP0034307A3 (en) 1981-11-18
IT8119760A0 (it) 1981-02-13
BE887529A (fr) 1981-08-17
EP0034307A2 (de) 1981-08-26
AU6728881A (en) 1981-08-27
ES499259A0 (es) 1982-12-01
GB2071108A (en) 1981-09-16
FR2478124A1 (fr) 1981-09-18
SE8101005L (sv) 1981-08-17
DE3176088D1 (en) 1987-05-14
NL8100718A (nl) 1981-09-16

Similar Documents

Publication Publication Date Title
ES499262A0 (es) Procedimiento para la obtencion de un microorganismo que forma un polipetido con la secuencia de aminoacidos del inter- feron de leucocitos humanos.
GB2090258B (en) Hybrid leukocyte interferon
HK49285A (en) Interferons and process for their preparation
NZ212937A (en) Omega interferons: production by recombinant dna processes; pharmaceutical compositions
EP0835661A3 (en) Human interferon-Beta2A for use as a medicament
ES499290A0 (es) Procedimiento para la preparacion de un microorganismo que forma polipeptido con la secuencia de aminoacidos del inter- feron de fibroblastos humanos.
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
IT8119180A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi della proinsulina di primati, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
ES2039390T3 (es) Un procedimiento para producir un factor de diferenciacion de celulas b humanas.